{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:54:37Z","timestamp":1790945677291,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8134","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.1038\/s41586-026-10899-5","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:01:49Z","timestamp":1785942109000},"page":"230-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Membranolytic peptide programs immunogenic cell death for cancer therapy"],"prefix":"10.1038","volume":"658","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6262-3452","authenticated-orcid":false,"given":"Yueling","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3741-8437","authenticated-orcid":false,"given":"Lifang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5992-3094","authenticated-orcid":false,"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1184-3429","authenticated-orcid":false,"given":"Chengrun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1610-9169","authenticated-orcid":false,"given":"Fuxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5260-526X","authenticated-orcid":false,"given":"Chanjuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7920-4857","authenticated-orcid":false,"given":"Jingxian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1252-2852","authenticated-orcid":false,"given":"Fan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5155-7285","authenticated-orcid":false,"given":"Zining","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9407-4054","authenticated-orcid":false,"given":"Rupei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4453-4226","authenticated-orcid":false,"given":"Yaofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6177-2322","authenticated-orcid":false,"given":"Xiongwei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0591-7477","authenticated-orcid":false,"given":"Jueqiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8681-3422","authenticated-orcid":false,"given":"Huosheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3880-5383","authenticated-orcid":false,"given":"Long","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8430-1646","authenticated-orcid":false,"given":"Yuhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0519-461X","authenticated-orcid":false,"given":"Penghui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2261-4532","authenticated-orcid":false,"given":"Tianmeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9328-5655","authenticated-orcid":false,"given":"Kaiting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-2556","authenticated-orcid":false,"given":"Zhibin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-1421","authenticated-orcid":false,"given":"Zhexiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1159-1224","authenticated-orcid":false,"given":"Shiyan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5867-8015","authenticated-orcid":false,"given":"Jianjun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5072-9428","authenticated-orcid":false,"given":"Yan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0020-5965","authenticated-orcid":false,"given":"Menghua","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"10899_CR1","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1016\/j.cell.2026.03.024","volume":"189","author":"M Conrad","year":"2026","unstructured":"Conrad, M. et al. Cell death in cancer. Cell 189, 2322\u20132356 (2026).","journal-title":"Cell"},{"key":"10899_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41568-025-00879-8","volume":"26","author":"C Mao","year":"2026","unstructured":"Mao, C., Jiang, D., Koong, A. C. & Gan, B. Exploiting metabolic cell death for cancer therapy. Nat. Rev. Cancer 26, 27\u201345 (2026).","journal-title":"Nat. Rev. Cancer"},{"key":"10899_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41586-022-05368-8","volume":"611","author":"RN Amaria","year":"2022","unstructured":"Amaria, R. N. et al. Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611, 155\u2013160 (2022).","journal-title":"Nature"},{"key":"10899_CR4","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","volume":"185","author":"Q Huang","year":"2022","unstructured":"Huang, Q. et al. The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell 185, 4049\u20134066 (2022).","journal-title":"Cell"},{"key":"10899_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"HA Tawbi","year":"2022","unstructured":"Tawbi, H. A. et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N. Engl. J. Med. 386, 24\u201334 (2022).","journal-title":"N. Engl. J. Med."},{"key":"10899_CR6","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma, P. et al. Immune checkpoint therapy\u2014current perspectives and future directions. Cell 186, 1652\u20131669 (2023).","journal-title":"Cell"},{"key":"10899_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s43018-022-00500-z","volume":"4","author":"P Gulhati","year":"2023","unstructured":"Gulhati, P. et al. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1\/CXCR2 results in antitumor immunity and durable response in pancreatic cancer. Nat. Cancer 4, 62\u201380 (2023).","journal-title":"Nat. Cancer"},{"key":"10899_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s43018-019-0003-0","volume":"1","author":"G Abril-Rodriguez","year":"2020","unstructured":"Abril-Rodriguez, G. et al. PAK4 inhibition improves PD-1 blockade immunotherapy. Nat. Cancer 1, 46\u201358 (2020).","journal-title":"Nat. Cancer"},{"key":"10899_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41586-020-2079-1","volume":"579","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. A bioorthogonal system reveals antitumour immune function of pyroptosis. Nature 579, 421\u2013426 (2020).","journal-title":"Nature"},{"key":"10899_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 579, 415\u2013420 (2020).","journal-title":"Nature"},{"key":"10899_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","volume":"606","author":"T Zhang","year":"2022","unstructured":"Zhang, T. et al. ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis. Nature 606, 594\u2013602 (2022).","journal-title":"Nature"},{"key":"10899_CR12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41590-018-0188-x","volume":"19","author":"S He","year":"2018","unstructured":"He, S. & Wang, X. RIP kinases as modulators of inflammation and immunity. Nat. Immunol. 19, 912\u2013922 (2018).","journal-title":"Nat. Immunol."},{"key":"10899_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41551-020-0599-5","volume":"4","author":"L Li","year":"2020","unstructured":"Li, L. et al. Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells. Nat. Biomed. Eng. 4, 1102\u20131116 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"10899_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier, P., Legrand, A. J., Adam, D. & Silke, J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat. Rev. Cancer 24, 299\u2013315 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"10899_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379\u2013395 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10899_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz, P., Pelegr\u00edn, P. & Shao, F. The gasdermins, a protein family executing cell death and inflammation. Nat. Rev. Immunol. 20, 143\u2013157 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"10899_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao, W., Wang, X., Zhou, Y., Wang, X. & Yu, Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct. Target. Ther. 7, 196 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10899_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202209379","volume":"35","author":"W Su","year":"2023","unstructured":"Su, W. et al. A dual-responsive STAT3 inhibitor nanoprodrug combined with oncolytic virus elicits synergistic antitumor immune responses by igniting pyroptosis. Adv. Mater. 35, e2209379 (2023).","journal-title":"Adv. Mater."},{"key":"10899_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41565-021-00950-z","volume":"16","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy. Nat. Nanotechnol. 16, 1130\u20131140 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"10899_CR20","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41563-026-02506-9","volume":"25","author":"B Chen","year":"2026","unstructured":"Chen, B. et al. In situ-generated vaccine-like pyroptosome for personalized cancer immunotherapy. Nat. Mater. 25, 856\u2013867 (2026).","journal-title":"Nat. Mater."},{"key":"10899_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41580-022-00564-w","volume":"24","author":"P Vandenabeele","year":"2023","unstructured":"Vandenabeele, P., Bultynck, G. & Savvides, S. N. Pore-forming proteins as drivers of membrane permeabilization in cell death pathways. Nat. Rev. Mol. Cell Biol. 24, 312\u2013333 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10899_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99\u2013103 (2017).","journal-title":"Nature"},{"key":"10899_CR23","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","volume":"24","author":"P Devant","year":"2023","unstructured":"Devant, P. & Kagan, J. C. Molecular mechanisms of gasdermin D pore-forming activity. Nat. Immunol. 24, 1064\u20131075 (2023).","journal-title":"Nat. Immunol."},{"key":"10899_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana, S., Malireddi, R. K. S. & Kanneganti, T.-D. Caspases in cell death, inflammation, and pyroptosis. Annu. Rev. Immunol. 38, 567\u2013595 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"10899_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nri.2015.7","volume":"16","author":"SM Man","year":"2016","unstructured":"Man, S. M. & Kanneganti, T.-D. Converging roles of caspases in inflammasome activation, cell death and innate immunity. Nat. Rev. Immunol. 16, 7\u201321 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"10899_CR26","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot, D., Latz, E. & Franklin, B. S. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell. Mol. Immunol. 18, 1106\u20131121 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"10899_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.it.2019.03.006","volume":"40","author":"N Peltzer","year":"2019","unstructured":"Peltzer, N. & Walczak, H. Cell death and inflammation\u2014a vital but dangerous liaison. Trends Immunol. 40, 387\u2013402 (2019).","journal-title":"Trends Immunol."},{"key":"10899_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton, K., Strasser, A., Kayagaki, N. & Dixit, V. M. Cell death. Cell 187, 235\u2013256 (2024).","journal-title":"Cell"},{"key":"10899_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41565-022-01085-5","volume":"17","author":"M Liu","year":"2022","unstructured":"Liu, M. et al. A transistor-like pH-sensitive nanodetergent for selective cancer therapy. Nat. Nanotechnol. 17, 541\u2013551 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"10899_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202001108","volume":"32","author":"W Shen","year":"2020","unstructured":"Shen, W. et al. Antineoplastic drug-free anticancer strategy enabled by host-defense-peptides-mimicking synthetic polypeptides. Adv. Mater. 32, e2001108 (2020).","journal-title":"Adv. Mater."},{"key":"10899_CR31","doi-asserted-by":"publisher","first-page":"12675","DOI":"10.1073\/pnas.1710408114","volume":"114","author":"M Xiong","year":"2017","unstructured":"Xiong, M. et al. Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides. Proc. Natl Acad. Sci. USA 114, 12675\u201312680 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10899_CR32","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1021\/jacs.2c00452","volume":"144","author":"N Shao","year":"2022","unstructured":"Shao, N. et al. Heterochiral \u03b2-peptide polymers combating multidrug-resistant cancers effectively without inducing drug resistance. J. Am. Chem. Soc. 144, 7283\u20137294 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"10899_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nnano.2009.153","volume":"4","author":"L Liu","year":"2009","unstructured":"Liu, L. et al. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat. Nanotechnol. 4, 457\u2013463 (2009).","journal-title":"Nat. Nanotechnol."},{"key":"10899_CR34","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1021\/jacs.4c14199","volume":"147","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. pH-ultrasensitive membranolytic polyesters with alternating sequence of ionizable and hydrophobic groups for selective oncolytic therapy. J. Am. Chem. Soc. 147, 1008\u20131016 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"10899_CR35","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1080\/15384101.2015.1093710","volume":"14","author":"S Forveille","year":"2015","unstructured":"Forveille, S. et al. The oncolytic peptide LTX-315 triggers necrotic cell death. Cell Cycle 14, 3506\u20133512 (2015).","journal-title":"Cell Cycle"},{"key":"10899_CR36","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/cdd.2016.35","volume":"23","author":"T Yamazaki","year":"2016","unstructured":"Yamazaki, T. et al. The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade. Cell Death Differ. 23, 1004\u20131015 (2016).","journal-title":"Cell Death Differ."},{"key":"10899_CR37","doi-asserted-by":"publisher","first-page":"10826","DOI":"10.1002\/anie.201706071","volume":"56","author":"M Xiong","year":"2017","unstructured":"Xiong, M. et al. Bacteria-assisted activation of antimicrobial polypeptides by a random-coil to helix transition. Angew. Chem. Int. Ed. 56, 10826\u201310829 (2017).","journal-title":"Angew. Chem. Int. Ed."},{"key":"10899_CR38","doi-asserted-by":"publisher","first-page":"1703461","DOI":"10.1002\/adma.201703461","volume":"29","author":"GB Qi","year":"2017","unstructured":"Qi, G. B., Zhang, D., Liu, F. H., Qiao, Z. Y. & Wang, H. An \u201con\u2013site transformation\u201d strategy for treatment of bacterial infection. Adv. Mater. 29, 1703461 (2017).","journal-title":"Adv. Mater."},{"key":"10899_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202401263","volume":"9","author":"W Zhang","year":"2025","unstructured":"Zhang, W. et al. The relationship between in vivo toxicity and responsive pH in transistor-like pH-sensitive nanodetergents. Small Methods 9, 2401263 (2025).","journal-title":"Small Methods"},{"key":"10899_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer, E. & Pedersen, S. F. The acidic tumor microenvironment as a driver of cancer. Annu. Rev. Physiol. 82, 103\u2013126 (2020).","journal-title":"Annu. Rev. Physiol."},{"key":"10899_CR41","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1021\/acs.accounts.8b00195","volume":"51","author":"J-Z Du","year":"2018","unstructured":"Du, J.-Z., Li, H.-J. & Wang, J. Tumor-acidity-cleavable maleic acid amide (TACMAA): a powerful tool for designing smart nanoparticles to overcome delivery barriers in cancer nanomedicine. Acc. Chem. Res. 51, 2848\u20132856 (2018).","journal-title":"Acc. Chem. Res."},{"key":"10899_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41580-023-00676-x","volume":"25","author":"C Settembre","year":"2024","unstructured":"Settembre, C. & Perera, R. M. Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology. Nat. Rev. Mol. Cell Biol. 25, 223\u2013245 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10899_CR43","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1080\/15548627.2015.1063871","volume":"11","author":"S Aits","year":"2015","unstructured":"Aits, S. et al. Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy 11, 1408\u20131424 (2015).","journal-title":"Autophagy"},{"key":"10899_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar5078","volume":"360","author":"ML Skowyra","year":"2018","unstructured":"Skowyra, M. L., Schlesinger, P. H., Naismith, T. V. & Hanson, P. I. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science 360, eaar5078 (2018).","journal-title":"Science"},{"key":"10899_CR45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/tra.12613","volume":"19","author":"F Wang","year":"2018","unstructured":"Wang, F., G\u00f3mez-Sintes, R. & Boya, P. Lysosomal membrane permeabilization and cell death. Traffic 19, 918\u2013931 (2018).","journal-title":"Traffic"},{"key":"10899_CR46","first-page":"206","volume":"31","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. From oncolytic peptides to oncolytic polymers: a new paradigm for oncotherapy. Bioact. Mater. 31, 206\u2013230 (2024).","journal-title":"Bioact. Mater."},{"key":"10899_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","volume":"23","author":"L Galluzzi","year":"2024","unstructured":"Galluzzi, L., Guilbaud, E., Schmidt, D., Kroemer, G. & Marincola, F. M. Targeting immunogenic cell stress and death for cancer therapy. Nat. Rev. Drug Discov. 23, 445\u2013460 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"10899_CR48","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","volume":"19","author":"J Kim","year":"2024","unstructured":"Kim, J., Eygeris, Y., Ryals, R. C., Jozi\u0107, A. & Sahay, G. Strategies for non-viral vectors targeting organs beyond the liver. Nat. Nanotechnol. 19, 428\u2013447 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"10899_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/science.adu7686","volume":"391","author":"Q Wang","year":"2026","unstructured":"Wang, Q. et al. Commensal-driven serotonin production modulates in vivo delivery of synthetic and viral vectors. Science 391, eadu7686 (2026).","journal-title":"Science"},{"key":"10899_CR50","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.immuni.2021.10.020","volume":"55","author":"E Duong","year":"2022","unstructured":"Duong, E. et al. Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity. Immunity 55, 308\u2013323 (2022).","journal-title":"Immunity"},{"key":"10899_CR51","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng, F. et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct. Target. Ther. 7, 286 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10899_CR52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41565-025-01857-9","volume":"20","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy. Nat. Nanotechnol. 20, 563\u2013574 (2025).","journal-title":"Nat. Nanotechnol."},{"key":"10899_CR53","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s11033-025-10997-z","volume":"52","author":"A Gemingnuer","year":"2025","unstructured":"Gemingnuer, A., Yin, R., Liu, Y., Tian, Y. & Meng, X. Lysosome-dependent cell death: disease implications and potential therapeutic targets. Mol. Biol. Rep. 52, 881 (2025).","journal-title":"Mol. Biol. Rep."},{"key":"10899_CR54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer, G., Galassi, C., Zitvogel, L. & Galluzzi, L. Immunogenic cell stress and death. Nat. Immunol. 23, 487\u2013500 (2022).","journal-title":"Nat. Immunol."},{"key":"10899_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L., Buqu\u00e9, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17, 97\u2013111 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"10899_CR56","doi-asserted-by":"publisher","first-page":"13155","DOI":"10.1073\/pnas.1507893112","volume":"112","author":"M Xiong","year":"2015","unstructured":"Xiong, M. et al. Helical antimicrobial polypeptides with radial amphiphilicity. Proc. Natl Acad. Sci. USA 112, 13155\u201313160 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10899_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1209","volume":"2","author":"H Lu","year":"2011","unstructured":"Lu, H. et al. Ionic polypeptides with unusual helical stability. Nat. Commun. 2, 206 (2011).","journal-title":"Nat. Commun."},{"key":"10899_CR58","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1158\/1535-7163.MCT-21-0203","volume":"20","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. SAGE1: a potential target antigen for lung cancer T-cell immunotherapy. Mol. Cancer Ther. 20, 2302\u20132313 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"10899_CR59","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.3910","volume":"21","author":"AP Rapoport","year":"2015","unstructured":"Rapoport, A. P. et al. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat. Med. 21, 914\u2013921 (2015).","journal-title":"Nat. Med."},{"key":"10899_CR60","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","volume":"24","author":"MM Tomayko","year":"1989","unstructured":"Tomayko, M. M. & Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148\u2013154 (1989).","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10899-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10899-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10899-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:02:57Z","timestamp":1790816577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10899-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":60,"journal-issue":{"issue":"8134","published-print":{"date-parts":[[2026,10,1]]}},"alternative-id":["10899"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10899-5","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.Y., J.L., Y.B. and M.X. have submitted a patent application (202111564284.3) related to this study. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}